Skip to content
Monday, December 2, 2024
Wall Street Insider
Deliver critical advise to busy investors
Search
Search
News
About Us
Services
Institutional Research
Portfolio Analysis
#1 Stock Pick
Subscriptions
Contact Us
CLIENT LOGIN
Home
News
Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidance
News
Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidance
November 7, 2024
Arthur Bleemer
Gilead Sciences Inc.’s stock rose 2.7% in after-hours trading Wednesday, after the biotech blew past third-quarter earnings estimates and raised its guidance, boosted by demand for its HIV and COVID-19 treatments.
Read more from source
Post navigation
Qualcomm’s rosy forecast sends stock surging, and more buybacks may be on deck
Lyft shares soar 20% on results and autonomous-vehicle partnership